// App-Quantinova.ai

BSH2020‐PO‐086 : Brentuximab vedotin plus bendamustine in relapsed and refractory classical Hodgkin lymphoma in children, adolescents and young adults: a single centre experience

Researchers

Presenter

  • A. McMillan

Principal Investigators

  • A. T. O'Neill

  • P. Humphries

  • J. Lambert

  • L. Menezes

  • R. Shah

  • W. Townsend

  • A. Virchis

  • K. Von Both

  • B. Carpenter

  • V. Grandage

  • R. Hough

  • K. M. Ardeshna

  • S. Daw

Medical Centers

  • Hematology

  • Radiology,

  • Pharmacy

  • Children and Young People's Cancer Services, University College London Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

Biomarkers

  • 18F-fluorodeoxyglucose

Drug/Treatment

  • Adcetris

  • Methylprednisolone

  • Diphenhydramine

  • Derma-Pax lotion

  • Chlorphenamine

  • Bendamustine

  • histamine

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • I/II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved